The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Emerging Biomarkers in Heart Failure
Abstract
BACKGROUND: Until recently, biomarker testing in heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patients suspected to suffer from this condition. This approach to the use of biomarker testing contrasts with other cardiovascular diagnoses such as acute myocardial infarction, for which biomarkers are integral to disease process definition, risk stratification, and in some cases treatment decision making. CONTENT: In this review we consider various perspectives on the evaluation of biomarkers in HF. In addition, we examine recent advances in the understanding of established biomarkers in HF (such as the natriuretic peptides), the elucidation of novel biomarkers potentially useful for the evaluation and management of patients with HF, and the growing understanding of important and relevant comorbidities in HF. We also review candidate biomarkers from a number of classes: (a) myocyte stretch, (b) myocyte necrosis, (c) systemic inflammation, (d) oxidative stress, (e) extracellular matrix turnover, (f) neurohormones, and (g) biomarkers of extracardiac processes, such as renal function. SUMMARY: Novel applications of established biomarkers of HF as well as elucidation and validation of emerging assays for HF syndromes have collectively led to a growing interest in the more widespread use of such testing in patients affected by the diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., & White, H. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.011 · Cited by 1,618
Jessup, M., & Brozena, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021498 · Cited by 1,564
Troughton, R. W., Frampton, C. M., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,376
Braunwald, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,257
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
Felker, G. M., Allen, L. A., Pocock, S. J., Shaw, L. K., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.067 · Cited by 947
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
Tonelli, M., Sacks, F., Arnold, M., Moye, L., Davis, B., & Pfeffer, M. (2008) · Circulation · doi:10.1161/circulationaha.107.727545 · Cited by 816
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Dual Action of Neutrophil Gelatinase–Associated Lipocalin
Schmidt-Ott, K. M., Mori, K., Li, J. Y., Kalandadze, A., Cohen, D. J., Devarajan, P., & Barasch, J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080882 · Cited by 772
Vasan, R. S., Sullivan, L. M., Roubenoff, R., Dinarello, C. A., Harris, T., Benjamin, E. J., Sawyer, D. B., Levy, D., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 746
Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655076 · Cited by 709
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., Kwong, R., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 696
Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651
van Kimmenade, R. R., Januzzi, J. L., Ellinor, P. T., Sharma, U. C., Bakker, J. A., Low, A. F., Martinez, A., Crijns, H. J., MacRae, C. A., Menheere, P. P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.061 · Cited by 567
Self-citationBenchmarks for the Assessment of Novel Cardiovascular Biomarkers
Morrow, D. A., & de Lemos, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.683110 · Cited by 561
Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea
Januzzi, J. L., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O’Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.014 · Cited by 522
Self-citationMid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea
Maisel, A., Mueller, C., Nowak, R., Peacock, W. F., Landsberg, J. W., Ponikowski, P., Mockel, M., Hogan, C., Wu, A. H. B., Richards, M., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.025 · Cited by 511
Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000047274.66749.fe · Cited by 503
Inflammatory Markers and Incident Heart Failure Risk in Older Adults
Kalogeropoulos, A., Georgiopoulou, V., Psaty, B. M., Rodondi, N., Smith, A. L., Harrison, D. G., Liu, Y., Hoffmann, U., Bauer, D. C., Newman, A. B., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.045 · Cited by 478
Lok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465
Anemia and Its Relationship to Clinical Outcome in Heart Failure
Anand, I., McMurray, J. J. V., Whitmore, J., Warren, M., Pham, A., McCamish, M. A., & Burton, P. B. J. (2004) · Circulation · doi:10.1161/01.cir.0000134279.79571.73 · Cited by 433
Cystatin C-Properties and use as diagnostic marker
(2001) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(01)35015-1 · Cited by 418
Allen, L. A., Felker, G. M., Mehra, M. R., Chiong, J. R., Dunlap, S. H., Ghali, J. K., Lenihan, D. J., Oren, R. M., Wagoner, L. E., Schwartz, T. A., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.11.003 · Cited by 418
Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K. K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N., & Danesh, J. (2009) · Circulation · doi:10.1161/circulationaha.109.884866 · Cited by 378
Seki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon;, J., & Lee, R. T. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.873240 · Cited by 365
Pacher, R., Stanek, B., Hülsmann, M., Koller-Strametz, J., Berger, R., Schuller, M., Hartter, E., Ogris, E., Frey, B., Heinz, G., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00520-x · Cited by 343
Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction
Salio, M., Chimenti, S., De Angelis, N., Molla, F., Maina, V., Nebuloni, M., Pasqualini, F., Latini, R., Garlanda, C., & Mantovani, A. (2008) · Circulation · doi:10.1161/circulationaha.107.749234 · Cited by 327
Anand, I. S., Kempf, T., Rector, T. S., Tapken, H., Allhoff, T., Jantzen, F., Kuskowski, M., Cohn, J. N., Drexler, H., & Wollert, K. C. (2010) · Circulation · doi:10.1161/circulationaha.109.928846 · Cited by 319
Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
Sarnak, M. J., Katz, R., Stehman-Breen, C. O., Fried, L. F., Jenny, N. S., Psaty, B. M., Newman, A. B., Siscovick, D., Shlipak, M. G., & Study*, A. T. C. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00008 · Cited by 315
Wilson Tang, W. H., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., COMMITTEE MEMBERS, Christenson, R. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185267 · Cited by 310
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
Yndestad, A., Landro, L., Ueland, T., Dahl, C. P., Flo, T. H., Vinge, L. E., Espevik, T., Froland, S. S., Husberg, C., Christensen, G., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp088 · Cited by 292
Red Blood Cell Distribution Width and 1-Year Mortality in Acute Heart Failure
van Kimmenade, R. R. J., Mohammed, A. A., Uthamalingam, S., van der Meer, P., Felker, G. M., & Januzzi, J. L. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp179 · Cited by 284
Self-citationDeficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
Norata, G. D., Marchesi, P., Pulakazhi Venu, V. K., Pasqualini, F., Anselmo, A., Moalli, F., Pizzitola, I., Garlanda, C., Mantovani, A., & Catapano, A. L. (2009) · Circulation · doi:10.1161/circulationaha.108.806547 · Cited by 277
Pascual-Figal, D. A., Manzano-Fernández, S., Boronat, M., Casas, T., Garrido, I. P., Bonaque, J. C., Pastor-Perez, F., Valdés, M., & Januzzi, J. L. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr047 · Cited by 262
Self-citationNatriuretic Peptide Testing in Heart Failure
Kim, H.-N., & Januzzi, J. L. (2011) · Circulation · doi:10.1161/circulationaha.110.979500 · Cited by 252
Self-citationDieplinger, B., Januzzi, J. L., Steinmair, M., Gabriel, C., Poelz, W., Haltmayer, M., & Mueller, T. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.010 · Cited by 240
Self-citationBerger, R., Moertl, D., Peter, S., Ahmadi, R., Huelsmann, M., Yamuti, S., Wagner, B., & Pacher, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.078 · Cited by 232
Schlittenhardt, D., Schober, A., Strelau, J., Bonaterra, G. A., Schmiedt, W., Unsicker, K., Metz, J., & Kinscherf, R. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0986-3 · Cited by 224
Zile, M. R., DeSantis, S. M., Baicu, C. F., Stroud, R. E., Thompson, S. B., McClure, C. D., Mehurg, S. M., & Spinale, F. G. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.958199 · Cited by 215
Neurohormonal Activation in Congestive Heart Failure and the Role of Vasopressin
Chatterjee, K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.003 · Cited by 202
Clinical outcome of renal tubular damage in chronic heart failure†
Damman, K., Masson, S., Hillege, H. L., Maggioni, A. P., Voors, A. A., Opasich, C., van Veldhuisen, D. J., Montagna, L., Cosmi, F., Tognoni, G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr190 · Cited by 198
Damman, K., Van Veldhuisen, D. J., Navis, G., Vaidya, V. S., Smilde, T. D. J., Westenbrink, B. D., Bonventre, J. V., Voors, A. A., & Hillege, H. L. (2010) · Heart · doi:10.1136/hrt.2010.194878 · Cited by 198
Suzuki, S., Takeishi, Y., Niizeki, T., Koyama, Y., Kitahara, T., Sasaki, T., Sagara, M., & Kubota, I. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.08.013 · Cited by 193
Evaluating the Clinical Utility of a Biomarker: A Review of Methods for Estimating Health Impact
Pletcher, M. J., & Pignone, M. P. (2011) · Circulation · doi:10.1161/circulationaha.110.943860 · Cited by 189
Shah, R. V., Chen-Tournoux, A. A., Picard, M. H., van Kimmenade, R. R. J., & Januzzi, J. L. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.833707 · Cited by 179
Self-citationMatsubara, J., Sugiyama, S., Nozaki, T., Sugamura, K., Konishi, M., Ohba, K., Matsuzawa, Y., Akiyama, E., Yamamoto, E., Sakamoto, K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.018 · Cited by 175
Cardiac inotropic actions of urocortin in conscious sheep
Parkes, D. G., Vaughan, J., Rivier, J., Vale, W., & May, C. N. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.5.h2115 · Cited by 169
Lin, Y., Lin, L., Wu, Y., Chien, K., Lee, C., Hsu, R., Chao, C., Wang, S., Hsein, Y.-C., Liao, L.-C., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.001 · Cited by 167
Moe, G. W., Marin-Garcia, J., Konig, A., Goldenthal, M., Lu, X., & Feng, Q. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00036.2004 · Cited by 162
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Gray, G. A., & Webb, D. J. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00101-5 · Cited by 154
Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure
van Kimmenade, R. R. J., Januzzi, J. L., Baggish, A. L., Lainchbury, J. G., Bayés‐Genís, A., Richards, M., & Pinto, Y. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.056 · Cited by 150
Self-citationA study of C-reactive protein in the serum of patients with congestive heart failure
Elster, S. K., Braunwald, E., & Wood, H. F. (1956) · American Heart Journal · doi:10.1016/0002-8703(56)90099-0 · Cited by 145
Alehagen, U. (2011) · JAMA · doi:10.1001/jama.2011.666 · Cited by 134
Damman, K., Chuen, M. J. N. K., MacFadyen, R. J., Lip, G. Y. H., Gaze, D. C., Collinson, P. O., Hillege, H. L., van Oeveren, W., Voors, A. A., & van Veldhuisen, D. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.065 · Cited by 132
Miller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E., & Jaffe, A. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.025 · Cited by 123
Sharma, U. C., Rhaleb, N., Pokharel, S., Harding, P., Rasoul, S., Peng, H., & Carretero, O. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2007 · Cited by 122
Use of Myeloperoxidase for Risk Stratification in Acute Heart Failure
Reichlin, T., Socrates, T., Egli, P., Potocki, M., Breidthardt, T., Arenja, N., Meissner, J., Noveanu, M., Reiter, M., Twerenbold, R., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.142257 · Cited by 119
Tentzeris, I., Járai, R., Farhan, S., Perkmann, T., Schwarz, M. A., Jakl, G., Wojta, J., & Huber, K. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr049 · Cited by 91
Klip, I. T., Voors, A. A., Anker, S. D., Hillege, H. L., Struck, J., Squire, I. B., van Veldhuisen, D. J., Dickstein, K., & for the OPTIMAAL investigators (2011) · Heart · doi:10.1136/hrt.2010.210948 · Cited by 86
Plasma urocortin in human systolic heart failure
Ng, L. L., Loke, I. W., O’Brien, R. J., Squire, I. B., & Davies, J. E. (2004) · Clinical Science · doi:10.1042/cs20030311 · Cited by 85
Tang, W. H. W., Katz, R., Brennan, M., Aviles, R. J., Tracy, R. P., Psaty, B. M., & Hazen, S. L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.026 · Cited by 76
Pro–B-Type Natriuretic Peptide1–108 Circulates in the General Community
Macheret, F., Boerrigter, G., McKie, P. M., Costello‐Boerrigter, L. C., Lahr, B. D., Heublein, D. M., Sandberg, S. M., Ikeda, Y., Cataliotti, A., Bailey, K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.005 · Cited by 75
Frantz, S., Störk, S., Michels, K. B., Eigenthaler, M., Ertl, G., Bauersachs, J. K., & Angermann, C. E. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.02.015 · Cited by 74
Manzano‐Fernández, S., Januzzi, J. L., García, M. B., Bonaque-González, J. C., Truong, Q. A., Pastor‐Pérez, F. J., Muñoz‐Esparza, C., Pastor, P., Albaladejo-Otón, M. D., Casas, T., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.644 · Cited by 71
Self-citationEndotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo
Patten, M., mer, E. K. X. E., nemann, J. B. X. F., Wenck, C., Thoenes, M., Wieland, T., & Long, C. S. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100612 · Cited by 69
Bayés‐Genís, A., Pascual-Figal, D. A., Januzzi, J. L., Maisel, A. S., Casas, T., Valdés, M., & Ordóñez‐Llanos, J. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70231-0 · Cited by 69
Self-citationShrestha, K. L., Borowski, A. G., Troughton, R. W., Thomas, J. D., Klein, A. L., & Tang, W. H. W. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.02.003 · Cited by 66
Bayés‐Genís, A., Pascual-Figal, D. A., Januzzi, J. L., Maisel, A. S., Casas, T., Chávarri, M. V., & Ordóñez‐Llanos, J. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70249-9 · Cited by 65
Self-citationKANOUPAKIS, E. M., Manios, E. G., Kallergis, E. M., Mavrakis, H. E., Goudis, C. A., Saloustros, I. G., Milathianaki, M. E., CHLOUVERAKIS, G. I., & Vardas, P. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.040 · Cited by 63
Mohammed, A. A., van Kimmenade, R. R. J., Richards, M., Bayés‐Genís, A., Pinto, Y. M., Moore, S. A., & Januzzi, J. L. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.915280 · Cited by 61
Self-citationThe evolution of the natriuretic peptides – Current applications in human and animal medicine
van Kimmenade, R. R. J., & Januzzi, J. L. (2009) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2009.01.001 · Cited by 54
Self-citationRademaker, M. T., Charles, C. J., Espiner, E. A., Frampton, C. M., Lainchbury, J. G., & Richards, M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi351 · Cited by 50
Plasma Urocortin 1 in Human Heart Failure
Wright, S. P., Doughty, R. N., Frampton, C. M., Gamble, G. D., Yandle, T. G., & Richards, M. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.840207 · Cited by 43
Buralli, S., Dini, F. L., Ballo, P., Conti, U., Fontanive, P., Duranti, E., Metelli, M. R., Marzilli, M., & Taddei, S. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.038 · Cited by 39
Baggish, A. L., van Kimmenade, R. R. J., Bayés‐Genís, A., Davis, M. E., Lainchbury, J. G., Frampton, C. M., Pinto, Y. M., Richards, M. A., & Januzzi, J. L. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.03.010 · Cited by 37
Self-citationShah, K. B., Kop, W. J., Christenson, R. H., Diercks, D. B., Kuo, D. C., Henderson, S., Hanson, K., Mehra, M. R., & deFilippi, C. R. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108159 · Cited by 27
Avellino, A., Collins, S. P., & Fermann, G. J. (2011) · Biomarkers · doi:10.3109/1354750x.2011.574234 · Cited by 22
Free and Easy? Red Cell Distribution Width (RDW) and Prognosis in Cardiac Disease
Means, R. T. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.01.008 · Cited by 12
AVP receptor antagonists in patients with CHF
Kumar, S. K., & Mather, P. J. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9107-9 · Cited by 9
Cited by
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 601
Self-citationBiomarkers and diagnostics in heart failure
Gaggin, H. K., & Januzzi, J. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.014 · Cited by 423
Self-citationHeart Failure: Diagnosis, Management and Utilization
Inamdar, A., & Inamdar, A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5070062 · Cited by 412
Risk stratification for sudden cardiac death: Current status and challenges for the future
Wellens, H. J. J., Schwartz, P. J., Lindemans, F. W., Buxton, A. E., Goldberger, J. J., Hohnloser, S. H., Huikuri, H. V., Kaab, S., La Rovere, M. T., Malik, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu176 · Cited by 405
Metadata
- Authors
- van Kimmenade, R. R. J., & Januzzi, J. L.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 127-138
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2039669614
- Cited by
- 257
- References
- 84
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.